Clinical trials
Phase 1 Multiple Sclerosis, Relapsing-Remitting trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2015 | 3 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| University of Wisconsin, Madison | 2 |
| Aaron Boster | 1 |
| Acorda Therapeutics | 1 |
| Anokion SA | 1 |
| Artielle ImmunoTherapeutics | 1 |
| Banner Life Sciences LLC | 1 |
| Elan Pharmaceuticals | 1 |
| Georgia State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 22 |
| Multiple Sclerosis | 17 |
| Multiple Sclerosis, Chronic Progressive | 5 |
| Autoimmune Diseases | 2 |
| Ataxia | 1 |
| Disease Progression | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.